Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien™ transcatheter heart valve or the Medtronic CoreValve® System in high-risk patients with aortic stenosis

Archives of Cardiovascular Diseases

Volumn 103, Issue 4, 2010, Pages 236-245

  Attias, David ^a   Himbert, Dominique ^a   Ducrocq, Gregory ^a   Détaint, Delphine ^a   Al Attar, Nawwar ^b   Lung, Bernard ^a   Francis, Fady ^b   Maury, Jean Michel ^b   Brochet, Eric ^a   Enguerrand, Daniel ^a   Nataf, Patrick ^b   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Aortic stenosis; Transcatheter aortic valve implantation; Transfemoral

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; FEMALE; HEART CATHETER; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL RATE; TRANSFEMORAL AORTIC VALVE IMPLANTATION; UNITED STATES; AORTIC VALVE STENOSIS; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CONTRAINDICATIONS; FEMORAL ARTERY; FRANCE; HEART CATHETERIZATION; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MORTALITY; PROSPECTIVE STUDY; PROSTHESIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; PARIS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954860710     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2010.03.006     Document Type: Article

References (21)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J 2003;24:1231-43. (Pubitemid 36834640)
2. Bonow RO, Carabello BA, Chatterjee K, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists. Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523-661.
3. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68.
4. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. (Pubitemid 35440280)
5. Vahanian A, Alfieri OR, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2008;34:1-8.
6. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
7. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
8. Eltchaninoff H, Zajarias A, Tron C, et al. Transcatheter aortic valve implantation: technical aspects, results and indications. Arch Cardiovasc Dis 2008;101:126-32.
9. De Robertis F, Asgar A, Davies S, et al. The left axillary artery - a new approach for transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2009;36:807-12.
10. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009;54:303-11.
11. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009-16.
12. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801-8. (Pubitemid 43244307)
13. Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebért R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet 1999;353:205-6. (Pubitemid 29088034)
14. Akins CW, Miller DC, Turina Ml, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 2008;135:732-8.
15. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7.
16. Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Over-estimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30:74-80.
17. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Intv 2008;1:310-6. (Pubitemid 351804194)
18. Lung B. Management of the elderly patient with aortic stenosis. Heart 2008;94:519-24.
19. Détaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. J Am Coll Cardiol Intv 2009;2:821-7.
20. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63. (Pubitemid 47255993)
21. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.